Mirum Pharmaceuticals, Inc.
MIRM
$43.45
$0.912.14%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -2.10% | -7.05% | -15.63% | 129.30% | 88.72% |
Total Receivables | 15.18% | 43.27% | 71.06% | 123.02% | 183.27% |
Inventory | 0.41% | -2.95% | 140.19% | 226.72% | 300.93% |
Prepaid Expenses | 7.76% | -3.27% | -11.71% | 11.46% | 22.22% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 1.35% | -0.50% | -4.09% | 125.99% | 103.73% |
|
|||||
Total Current Assets | 1.35% | -0.50% | -4.09% | 125.99% | 103.73% |
Net Property, Plant & Equipment | 393.17% | 367.13% | 297.58% | -45.43% | -15.14% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -1.23% | -0.98% | 363.82% | 346.21% | 329.02% |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 39.42% | 284.44% | 266.18% | -96.18% | -95.89% |
Total Assets | 3.73% | 2.65% | 48.96% | 95.47% | 83.23% |
|
|||||
Total Accounts Payable | 97.11% | 29.53% | -31.87% | 148.18% | -14.66% |
Total Accrued Expenses | 32.73% | 37.41% | 26.82% | 22.68% | 58.04% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 54.80% | 39.19% | 0.75% | -60.83% | 18.58% |
Total Finance Division Other Current Liabilities | 57.97% | 107.55% | -- | 3,570.18% | 16.08% |
Total Other Current Liabilities | 57.97% | 107.55% | -- | 3,570.18% | 16.08% |
Total Current Liabilities | 45.35% | 55.03% | 92.96% | 116.84% | 34.51% |
|
|||||
Total Current Liabilities | 45.35% | 55.03% | 92.96% | 116.84% | 34.51% |
Long-Term Debt | 0.54% | 0.54% | 0.53% | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 1,192.06% | 876.96% | 614.38% | -68.91% | -50.91% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -34.81% | 56,642.86% | 39,620.00% | -96.99% | -97.34% |
Total Liabilities | 11.85% | 14.23% | 18.30% | 116.95% | 88.72% |
|
|||||
Common Stock & APIC | 8.33% | 7.63% | 45.19% | 44.71% | 50.12% |
Retained Earnings | -15.81% | -19.17% | -21.96% | -37.49% | -41.60% |
Treasury Stock & Other | -122.69% | 163.10% | -727.63% | -109.56% | 857.60% |
Total Common Equity | -9.26% | -13.77% | 191.30% | 66.21% | 75.07% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -9.26% | -13.77% | 191.30% | 66.21% | 75.07% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -9.26% | -13.77% | 191.30% | 66.21% | 75.07% |
|